Identification of a Novel Metastasis-suppressor Region on Human Chromosome 12
Overview
Authors
Affiliations
There is a critical need for markers that can be used to predict accurately the malignant potential of histological prostate cancers (J. T. Isaacs. Am. J. Pathol., 150: 1511-1521, 1997). Metastasis-suppressor genes are attractive candidates for marker development because, by definition, their loss should be associated with the acquisition of metastatic ability. In an effort to identify such genes, a single copy of human chromosome 12, tagged with the neomycin resistance gene, was introduced into highly metastatic Dunning AT6.1 prostate cancer cells by microcell-mediated chromosomal transfer. Thirty-two AT6.1-12 clonal cell lines were established and the region(s) of chromosome 12 retained was determined by sequence tagged site-based PCR analysis. Representative AT6.1-12 clones containing overlapping regions of chromosome 12 were characterized cytogenetically and were shown to have a normal complement of parental AT6.1 rat chromosomes. Fluorescence in situ hybridization, performed on representative AT6.1-12 hybrids, demonstrated a single human chromosome 12-specific signal. The metastatic ability of six representative clones was tested in immunodeficient mice. All of the AT6.1-12 clones showed the same in vivo growth rates as the control AT6.1-neo cells. Clonal cell lines that contained a conserved approximately 70-cM portion of chromosome 12 (e.g., AT6.1-12-8, -8-1, and -8-3), showed a >30-fold suppression in the number of macroscopic surface lung metastases. Mice that received injections of these cells developed a mean number 4 lung metastases whereas mice that received injections of other AT6.1-12 hybrids (lacking the approximately 70-cM region) or AT6.1-neo control cells, developed a mean number of 140 metastases. Interestingly, histological examination of the lungs of the mice that received injections of AT6.1-12-8 cells showed essentially no microscopic metastases. These findings suggest that a gene(s) encoded by the approximately 70-cM portion of human chromosome 12 suppresses an early step in the metastatic cascade.
Luther G, Lamplot J, Chen X, Rames R, Wagner E, Liu X Cancer Lett. 2013; 336(1):222-30.
PMID: 23665505 PMC: 3704951. DOI: 10.1016/j.canlet.2013.05.002.
Yan J, Yang Q, Huang Q Histol Histopathol. 2013; 28(3):285-92.
PMID: 23348381 PMC: 3910084. DOI: 10.14670/HH-28.285.
Genomics screens for metastasis genes.
Yan J, Huang Q Cancer Metastasis Rev. 2012; 31(3-4):419-28.
PMID: 22684367 PMC: 4071451. DOI: 10.1007/s10555-012-9362-z.
Reis A, Mills W, Ramachandran I, Friedberg E, Thompson D, Queimado L Nucleic Acids Res. 2011; 40(1):206-19.
PMID: 21911361 PMC: 3245927. DOI: 10.1093/nar/gkr704.
Suppressive roles of calreticulin in prostate cancer growth and metastasis.
Alur M, Nguyen M, Eggener S, Jiang F, Dadras S, Stern J Am J Pathol. 2009; 175(2):882-90.
PMID: 19608864 PMC: 2716982. DOI: 10.2353/ajpath.2009.080417.